| Period Ending | 31-Mar-2010 | 31-Mar-2009 | 31-Mar-2008 | 31-Mar-2007 |
|---|
|
Total Revenue
|
2,502,205,000
|
2,862,330,000
|
2,280,114,000
|
2,000,045,000
| | Cost of Revenue | 2,213,971,000 | 2,653,285,000 | 2,014,874,000 | 1,772,421,000 | | |
Gross Profit
|
288,233,000
|
209,045,000
|
265,239,000
|
227,624,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 2,402,684,000 | 2,832,929,000 | 2,169,316,000 | 1,911,264,000 | | | |
Operating Income or Loss
|
99,520,000
|
29,401,000
|
110,798,000
|
88,781,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 99,520,000 | 29,401,000 | 110,798,000 | 88,781,000 |
|
Interest Expense | (17,262,000) | (42,076,000) | (18,000,000) | (17,430,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 40,499,000 | 12,533,000 | 39,381,000 | 34,324,000 |
|
Minority Interest | (2,855,000) | 2,036,000 | (6,378,000) | (3,119,000) |
|
|
|
Net Income From Continuing Ops | 107,132,000 | 25,994,000 | 79,127,000 | 78,675,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
107,132,000
|
25,994,000
|
79,127,000
|
78,675,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|